查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1379133

2023-2028 年按产品类型（智慧血糖仪、智慧胰岛素帮浦、智慧胰岛素笔、应用程式）、装置类型（手持装置、穿戴式装置）和区域分類的数位糖尿病管理市场报告

Digital Diabetes Management Market Report by Product Type (Smart Glucose Meter, Smart Insulin Pumps, Smart Insulin Pens, Apps), Device Type (Handheld Devices, Wearable Devices), and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年全球数位糖尿病管理市场规模达108亿美元。展望未来， IMARC Group预计到2028年市场规模将达到360亿美元，2022-2028年复合年增长率（CAGR）为22.2%。糖尿病盛行率的上升、重大的技术进步、向以患者为中心的护理的转变、有利的政府倡议、人工智慧整合、远距医疗和远端患者监测解决方案的日益采用以及战略合作是推动市场的一些主要因素。

数位化糖尿病管理是指利用科技和数位解决方案帮助个人监测和控制其糖尿病状况。这些数位工具和应用程式提供各种功能，有助于追踪血糖水平、药物依从性、身体活动和饮食摄取量。透过利用智慧型手机、穿戴式装置和云端的平台，数位糖尿病管理可以实现即时资料收集和分析，促进患者更好的自我管理和参与。数位糖尿病管理的主要优势之一是它能够根据收集的资料提供个人化的见解和可行的建议。这使患者能够对其生活方式选择和治疗计划做出明智的决定。此外，医疗保健提供者可以全面了解患者的健康状况，以便在必要时进行远端监控和及时干预。此外，这些技术透过互动功能和教育资源促进持续参与和积极性，有助于改善患者的治疗效果。它们还促进患者和医疗保健专业人员之间的无缝沟通，从而增强整体护理体验。

全球糖尿病盛行率不断上升，对有效、便利的糖尿病管理解决方案产生了巨大需求。数位糖尿病管理工具提供即时监控和个人化护理，使其成为患者和医疗保健提供者等有吸引力的选择。此外，在糖尿病照护中，人们越来越重视患者赋权和自我管理。数位糖尿病管理解决方案透过提供轻鬆的资讯取得、个人化见解以及监测和依从性工具，使患者能够掌控自己的健康。除此之外，将人工智慧和机器学习演算法整合到数位糖尿病管理平台中可以实现预测分析和个人化建议。这些技术增强了治疗计划和干预措施，推动了市场需求。除此之外，远距医疗和远距患者监测解决方案的日益普及进一步推动了对数位糖尿病管理工具的需求。这些技术使医疗保健提供者能够远端监控患者的健康状况并在必要时进行干预，从而改善患者护理和便利性。与此一致的是，市场见证了数位健康公司和製药公司之间的合作，从而实现了糖尿病管理解决方案与药物和治疗方案的整合。这种合作伙伴关係扩大了市场范围并增强了产品供应。此外，在糖尿病照护中，人们越来越重视患者赋权和自我管理。数位糖尿病管理解决方案透过提供轻鬆的资讯取得、个人化见解以及监测和依从性工具，使患者能够掌控自己的健康。此外，各国政府正在积极推动数位健康解决方案，包括数位糖尿病管理，以改善医疗结果并降低医疗成本。激励和支持政策进一步推动了市场的成长。

数位糖尿病管理市场趋势/驱动因素：

技术进步

智慧型手机、穿戴式装置和网路连线的出现彻底改变了患者和医疗保健提供者管理糖尿病的方式。这些进步使得用户友好的行动应用程式和穿戴式装置的开发成为可能，从而促进无缝资料收集，例如血糖水平和身体活动。此外，基于云端的平台已经出现，可以即时安全地储存和分析患者的健康资料。资料分析和人工智慧的整合透过提供个人化见解和预测分析，进一步增强了这些解决方案的功能，使患者能够就糖尿病管理做出明智的决策。总体而言，技术进步显着提高了数位糖尿病管理工具的有效性和可近性，使其成为现代医疗保健不可或缺的一部分。

自我管理意识不断增强

数位化糖尿病管理解决方案在推动这一趋势方面发挥了至关重要的作用。这些工具让患者能够独立监测自己的健康和生活习惯，让他们有掌控自己病情的感觉。透过直觉的介面和教育资源，数位平台向患者传授糖尿病管理知识，包括饮食选择、运动习惯和药物依从性。透过积极让患者参与护理，这些解决方案可以提高治疗依从性和整体健康结果。此外，透过数位平台存取健康资料以及与医疗保健提供者沟通的便利性促进了患者的更多参与，从而形成了更具协作性的糖尿病管理方法。

有利的政府倡议

世界各国政府已经认识到数位医疗解决方案在改善医疗保健服务和结果方面的潜在好处。因此，他们实施了各种措施和政策来支持采用数位糖尿病管理和其他数位健康技术。已向医疗保健组织和技术公司提供激励、补贴和赠款，以鼓励开发和部署创新的数位糖尿病管理解决方案。此外，还建立了监管框架来确保这些技术的安全性和有效性。这些支持措施为市场成长、吸引投资和促进创新创造了有利的环境。因此，全球数位糖尿病管理市场经历了显着扩张，公共和私营部门之间的合作不断增加，以推动该领域的进步。

数位糖尿病管理产业细分：

IMARC Group提供了全球数位糖尿病管理市场报告各细分市场主要趋势的分析，以及 2023-2028 年全球、区域和国家层面的预测。我们的报告根据产品类型和设备类型对市场进行了分类。

按产品类型划分：

智慧型血糖仪

智慧胰岛素泵

智慧胰岛素笔

应用

智慧血糖仪占据市场主导地位

该报告根据产品类型对市场进行了详细的细分和分析。这包括智慧血糖仪、智慧胰岛素帮浦、智慧胰岛素笔和应用程式。报告称，智慧血糖仪占据了最大的细分市场。

智慧血糖仪提供先进的功能和连接选项，满足对技术先进的糖尿病管理解决方案不断增长的需求。这些设备可以与智慧型手机和其他数位平台无缝同步，使用户可以轻鬆存取即时血糖资料。此外，全球糖尿病盛行率不断上升，导致对准确且使用者友善的血糖监测设备的需求增加。智慧型血糖仪可提供精确的读数，降低糖尿病管理出错的风险，并提高患者对治疗计划的依从性。除此之外，糖尿病照护中对自我管理和患者赋权的重视进一步推动了智慧血糖仪的普及。这些设备使个人能够独立追踪自己的血糖水平，促进积极主动的糖尿病管理方法并培养对病情的控制感。此外，医疗保健提供者越来越多地采用远距医疗和远端监控解决方案，而智慧血糖仪正好符合这一趋势。将资料远端传输给医疗保健专业人员的能力有助于及时干预和个人化护理，使这些设备成为现代糖尿病管理中不可或缺的工具。

依设备类型细分：

手持装置

穿戴式装置

穿戴式装置占据最大市场份额

报告还根据设备类型提供了详细的市场细分和分析。这包括手持设备和穿戴式装置。报告显示，穿戴式装置占据了最大的市场份额。

穿戴式装置提供了一种无缝且非侵入性的方式来监测各种健康参数，这对于寻求持续健康追踪而又不中断日常生活的个人来说非常有吸引力。在糖尿病管理的背景下，配备感测器的穿戴式装置可以监测血糖水平、体力活动、心率和其他相关资料。此外，包括糖尿病在内的慢性病的盛行率不断上升，推动了对个人化和主动医疗保健解决方案的需求。穿戴式装置可实现即时资料收集和分析，为使用者提供有关其健康状况和管理病情进展的宝贵见解。除此之外，穿戴式装置见证了显着的技术进步，提高了其准确性、功能和整体使用者体验。这些创新扩大了穿戴式装置的范围，使其成为满足各种医疗保健需求（包括糖尿病管理）的多功能工具。此外，穿戴式装置与智慧型手机和其他数位平台的整合促进了无缝资料共享、与医疗保健提供者的通讯以及与其他数位健康应用程式的整合。这种连接性进一步提高了穿戴式装置在医疗保健生态系统中的价值。此外，人们对预防性医疗保健和健康的日益关注推动了注重健康的个人对穿戴式装置的采用，使其成为主流趋势。便利性、个人化见解、技术进步以及向主动健康管理的转变相结合，推动可穿戴设备成为数位健康设备市场的最大部分，包括那些专为糖尿病管理而设计的设备。

按地区划分：

北美洲

美国

加拿大

亚太

中国

日本

印度

韩国

澳洲

印尼

其他的

欧洲

德国

法国

英国

义大利

西班牙

俄罗斯

其他的

拉丁美洲

巴西

墨西哥

其他的

中东和非洲

北美在市场上表现出明显的主导地位

该报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告称，北美是数位糖尿病管理的最大市场。

北美的糖尿病盛行率很高，1 型和 2 型糖尿病影响了很大一部分人口。庞大的患者群体对创新、有效的糖尿病管理解决方案（包括数位技术）产生了强烈需求。此外，该地区拥有发达的医疗基础设施和先进的技术能力。该地区处于数位医疗采用的前沿，智慧型手机、穿戴式装置和远距医疗平台的广泛使用。这种技术准备促进了医疗保健系统和患者群体中数位糖尿病管理工具的整合和采用。此外，促进数位医疗采用的有利政府政策和措施进一步加速了市场的成长。这些政策包括鼓励医疗保健提供者采用数位解决方案、对远距医疗服务的报销支持以及鼓励数位医疗技术创新的监管框架。此外，北美数位健康产业的主要参与者和精通科技的新创公司的存在也促成了一个充满活力和竞争的市场。这些公司投资于研发，产生了广泛的尖端数位糖尿病管理解决方案，可满足各种患者的需求。

竞争格局：

市场主要参与者在研发方面投入巨资，以提高数位糖尿病管理解决方案的能力。他们不断升级智慧血糖仪、穿戴式装置、行动应用程式和云端平台，为用户提供增强的功能、更高的准确性和更好的用户体验。将人工智慧、机器学习和资料分析整合到这些解决方案中，实现了个人化见解、预测分析和更有效的治疗建议。此外，主要参与者还与各个利害关係人建立了合作和伙伴关係，以扩大其市场范围并增强产品供应。这些合作伙伴关係通常涉及製药公司、医疗保健提供者和远距医疗平台。透过将数位糖尿病管理解决方案与药物治疗、电子健康记录和远距医疗服务相结合，这些公司可以为糖尿病患者提供全面、无缝的医疗保健体验。除此之外，了解患者参与和赋权在糖尿病护理中的重要性，主要参与者专注于开发用户友好且以患者为中心的解决方案。他们优先考虑使用者体验，提供直觉的介面、教育资源和个人化指导，以鼓励自我管理和生活方式的改变。目标是促进长期参与和遵守治疗计划，从而改善患者的健康结果。除此之外，认识到健康资料的敏感性，主要参与者都非常重视资料安全和隐私。它们符合 HIPAA（健康保险流通与责任法案）和 GDPR（一般资料保护规范）等监管标准，确保病患资讯的安全储存和传输。这种对资料安全的承诺在使用者和医疗保健专业人员之间建立了信任，进一步推动了数位糖尿病管理解决方案的采用。

市场研究报告对市场竞争格局进行了全面分析。也提供了所有主要公司的详细资料。市场上的一些主要参与者包括：

雅培实验室

艾康实验室公司

Ascensia 糖尿病照护控股公司（PHC 控股公司）

贝克顿迪金森公司

德克斯康沃尔

F.霍夫曼-拉罗氏股份公司

美敦力公司

诺和诺德公司

Tandem 糖尿病护理公司

泰尔茂株式会社

最近的发展：

生物技术和製药行业的两家知名企业诺和诺德公司(Novo Nordisk A/S) 和Aspect Biosystems 最近宣布建立战略合作伙伴关係，其共同目标是推进生物打印组织疗法的开发，以应对糖尿病和肥胖症的挑战。此次合作代表了再生医学领域向前迈出的重要一步，并为患有这些慢性代谢性疾病的患者带来了广阔的前景。

Tandem Diabetes Care Inc. 最近发表了一项涉及其 Control-IQ 技术的重要荟萃分析结果。这项综合研究表明，自动校正推注对第 1 型糖尿病患者的血糖控制具有积极的临床影响，代表了糖尿病护理的重大进步。

Terumo Corporation 和专门从事糖尿病管理的着名数位健康平台 Glooko 共同宣布开展合作，旨在开发一种用于糖尿病资料共享的新型创新解决方案。此次合作汇集了 Terumo 在医疗设备方面的专业知识和 Glooko 在数位健康技术方面的熟练程度，最终目标是透过改善资料可近性和连接性来加强糖尿病护理。

本报告回答的关键问题：

  • 迄今为止，全球数位糖尿病管理市场表现如何，未来几年将如何表现？
  • 全球数位糖尿病管理市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球数位糖尿病管理市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的数位糖尿病管理市场？
  • 依产品类型分類的市场是怎么样的？
  • 数位糖尿病管理市场中最具吸引力的产品类型是什么？
  • 根据设备类型分類的市场是怎么样的？
  • 数位糖尿病管理市场中哪种设备类型最具吸引力？
  • 全球数位化糖尿病管理市场的竞争格局如何？
  • 全球数位糖尿病管理市场的主要参与者/公司有哪些？

本报告回答的关键问题：

  • 迄今为止，全球数位糖尿病管理市场表现如何，未来几年将如何表现？
  • 全球数位糖尿病管理市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球数位糖尿病管理市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的数位糖尿病管理市场？
  • 依产品类型分類的市场是怎么样的？
  • 数位糖尿病管理市场中最具吸引力的产品类型是什么？
  • 根据设备类型分類的市场是怎么样的？
  • 数位糖尿病管理市场中哪种设备类型最具吸引力？
  • 全球数位化糖尿病管理市场的竞争格局如何？
  • 全球数位糖尿病管理市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球数位糖尿病管理市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：依产品类型分類的市场区隔

  • 智慧型血糖仪
    • 市场走向
    • 市场预测
  • 智慧胰岛素泵
    • 市场走向
    • 市场预测
  • 智慧胰岛素笔
    • 市场走向
    • 市场预测
  • 应用
    • 市场走向
    • 市场预测

第 7 章：按设备类型分類的市场细分

  • 手持装置
    • 市场走向
    • 市场预测
  • 穿戴式装置
    • 市场走向
    • 市场预测

第 8 章：按地区分類的市场区隔

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 9 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 10 章：价值链分析

第 11 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 12 章：价格分析

第13章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • ACON Laboratories Inc
    • Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation)
    • Becton, Dickinson and Company
    • Dexcom Inc.
    • F. Hoffmann-La Roche AG
    • Medtronic plc
    • Novo Nordisk A/S
    • Tandem Diabetes Care Inc.
    • Terumo Corporation
Product Code: SR112023A4081

Abstract

The global digital diabetes management market size reached US$ 10.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 36.0 Billion by 2028, exhibiting a growth rate (CAGR) of 22.2% during 2022-2028. The rising prevalence of diabetes, significant technological advancements, a shift toward patient-centric care, favorable government initiatives, AI integration, increasing adoption of telehealth and remote patient monitoring solutions, and strategic collaborations are some of the major factors propelling the market.

Digital diabetes management refers to the utilization of technology and digital solutions to assist individuals in monitoring and controlling their diabetes condition. These digital tools and applications offer various functionalities that aid in tracking blood glucose levels, medication adherence, physical activity, and dietary intake. By leveraging smartphones, wearable devices, and cloud-based platforms, digital diabetes management enables real-time data collection and analysis, fostering better self-management and engagement for patients. One of the key advantages of digital diabetes management is its ability to provide personalized insights and actionable recommendations based on the data collected. This empowers patients to make informed decisions about their lifestyle choices and treatment plans. Additionally, healthcare providers can access a comprehensive view of the patient's health, allowing for remote monitoring and timely interventions when necessary. Furthermore, these technologies contribute to better patient outcomes by promoting continuous engagement and motivation through interactive features and educational resources. They also facilitate seamless communication between patients and healthcare professionals, enhancing the overall care experience.

The rising prevalence of diabetes worldwide has created a significant demand for effective and convenient solutions to manage the condition. Digital diabetes management tools offer real-time monitoring and personalized care, making them attractive options for patients and healthcare providers alike. Additionally, there is a growing emphasis on patient empowerment and self-management in diabetes care. Digital diabetes management solutions empower patients to take control of their health by providing easy access to information, personalized insights, and tools for monitoring and adherence. Other than this, the integration of artificial intelligence and machine learning algorithms into digital diabetes management platforms has enabled predictive analysis and personalized recommendations. These technologies enhance treatment plans and interventions, driving market demand. Besides this, the increasing adoption of telehealth and remote patient monitoring solutions has further fueled the demand for digital diabetes management tools. These technologies enable healthcare providers to remotely monitor patients' health and intervene when necessary, improving patient care and convenience. In line with this, the market has witnessed collaborations between digital health companies and pharmaceutical firms, leading to the integration of diabetes management solutions with medication and treatment regimens. Such partnerships expand the market reach and enhance product offerings. Furthermore, there is a growing emphasis on patient empowerment and self-management in diabetes care. Digital diabetes management solutions empower patients to take control of their health by providing easy access to information, personalized insights, and tools for monitoring and adherence. Moreover, governments in various countries are actively promoting the adoption of digital health solutions, including digital diabetes management, to improve healthcare outcomes and reduce healthcare costs. Incentives and supportive policies have further boosted the market's growth.

Digital Diabetes Management Market Trends/Drivers:

Technological Advancements

The advent of smartphones, wearable devices, and internet connectivity has revolutionized the way patients and healthcare providers manage diabetes. These advancements have enabled the development of user-friendly mobile applications and wearable gadgets that facilitate seamless data collection, such as blood glucose levels and physical activity. Additionally, cloud-based platforms have emerged, allowing secure storage and analysis of patients' health data in real-time. The integration of data analytics and artificial intelligence has further enhanced the capabilities of these solutions by providing personalized insights and predictive analysis, empowering patients to make informed decisions about their diabetes management. Overall, technological advancements have significantly improved the effectiveness and accessibility of digital diabetes management tools, making them an integral part of modern healthcare.

Growing Awareness About Self-Management

Digital diabetes management solutions have played a crucial role in promoting this trend. These tools offer patients the ability to monitor their health and lifestyle habits independently, providing them with a sense of control over their condition. Through intuitive interfaces and educational resources, digital platforms educate patients about diabetes management, including dietary choices, exercise routines, and medication adherence. By actively involving patients in their care, these solutions improve treatment compliance and overall health outcomes. Additionally, the convenience of accessing health data and communicating with healthcare providers through digital platforms fosters greater patient engagement, leading to a more collaborative approach to diabetes management.

Favorable Government Initiatives

Governments worldwide have recognized the potential benefits of digital health solutions in improving healthcare delivery and outcomes. Consequently, they have implemented various initiatives and policies to support the adoption of digital diabetes management and other digital health technologies. Incentives, subsidies, and grants have been provided to healthcare organizations and technology companies to encourage the development and deployment of innovative digital diabetes management solutions. Moreover, regulatory frameworks have been established to ensure the safety and efficacy of these technologies. These supportive measures have created a conducive environment for market growth, attracting investment and fostering innovation. As a result, the global digital diabetes management market has experienced significant expansion, with increasing collaborations between public and private sectors to drive advancements in this domain.

Digital Diabetes Management Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global digital diabetes management market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on product type and device type.

Breakup by Product Type:

Smart Glucose Meter

Smart Insulin Pumps

Smart Insulin Pens

Apps

Smart glucose meter dominates the market

The report has provided a detailed breakup and analysis of the market based on the product type. This includes smart glucose meter, smart insulin pumps, smart insulin pens, and apps. According to the report, smart glucose meter represented the largest segment.

Smart glucose meters offer advanced features and connectivity options that cater to the growing demand for technologically sophisticated diabetes management solutions. These devices can seamlessly sync with smartphones and other digital platforms, allowing users to access their real-time blood glucose data conveniently. Additionally, the rising prevalence of diabetes worldwide has led to an increased demand for accurate and user-friendly glucose monitoring devices. Smart glucose meters provide precise readings, reducing the risk of errors in diabetes management and enhancing patient compliance with treatment plans. Other than this, the emphasis on self-management and patient empowerment in diabetes care has further boosted the popularity of smart glucose meters. These devices enable individuals to track their glucose levels independently, promoting a proactive approach to diabetes management and fostering a sense of control over the condition. Moreover, healthcare providers are increasingly adopting telehealth and remote monitoring solutions, and smart glucose meters align well with this trend. The ability to remotely transmit data to healthcare professionals facilitates timely interventions and personalized care, making these devices indispensable tools in modern diabetes management.

Breakup by Device Type:

Handheld Devices

Wearable Devices

Wearable devices hold the largest share in the market

A detailed breakup and analysis of the market based on the device type has also been provided in the report. This includes handheld devices and wearable devices. According to the report, wearable devices accounted for the largest market share.

Wearable devices offer a seamless and non-intrusive way to monitor various health parameters, making them highly attractive to individuals seeking continuous health tracking without disruption to their daily routines. In the context of diabetes management, wearable devices equipped with sensors can monitor blood glucose levels, physical activity, heart rate, and other relevant data. Additionally, the increasing prevalence of chronic diseases, including diabetes, has driven the demand for personalized and proactive healthcare solutions. Wearable devices enable real-time data collection and analysis, providing users with valuable insights into their health status and progress in managing their condition. Other than this, wearable devices have witnessed remarkable technological advancements, enhancing their accuracy, functionality, and overall user experience. These innovations have broadened the scope of wearable devices, making them versatile tools that cater to diverse healthcare needs, including diabetes management. Furthermore, the integration of wearable devices with smartphones and other digital platforms has facilitated seamless data sharing, communication with healthcare providers, and integration with other digital health applications. This connectivity has further enhanced the value of wearable devices in the healthcare ecosystem. Moreover, the growing focus on preventive healthcare and wellness has fueled the adoption of wearable devices by health-conscious individuals, making them a mainstream trend. The combination of convenience, personalized insights, technological advancements, and the shift towards proactive health management has propelled wearable devices to become the largest segment in the market for digital health devices, including those designed for diabetes management.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for digital diabetes management.

North America has a high prevalence of diabetes, with both type 1 and type 2 diabetes affecting a significant portion of the population. This substantial patient pool has created a strong demand for innovative and effective diabetes management solutions, including digital technologies. Additionally, the region has a well-developed healthcare infrastructure and advanced technological capabilities. The region is at the forefront of digital health adoption, with extensive usage of smartphones, wearables, and telehealth platforms. This technological readiness has facilitated the integration and adoption of digital diabetes management tools across healthcare systems and patient populations. Furthermore, favorable government policies and initiatives promoting digital health adoption have further accelerated the growth of the market. These policies include incentives for healthcare providers to adopt digital solutions, reimbursement support for telehealth services, and regulatory frameworks that encourage innovation in digital health technologies. Moreover, the presence of major players and tech-savvy startups in the digital health industry within North America has contributed to a vibrant and competitive market. These companies have invested in research and development, resulting in a wide range of cutting-edge digital diabetes management solutions that cater to various patient needs.

Competitive Landscape:

Major players in the market have invested heavily in research and development to advance the capabilities of digital diabetes management solutions. They continuously upgrade their smart glucose meters, wearable devices, mobile applications, and cloud-based platforms to provide users with enhanced functionalities, improved accuracy, and better user experiences. Integration of artificial intelligence, machine learning, and data analytics into these solutions has enabled personalized insights, predictive analysis, and more effective treatment recommendations. Additionally, key players have formed collaborations and partnerships with various stakeholders to expand their market reach and enhance product offerings. These partnerships often involve pharmaceutical companies, healthcare providers, and telehealth platforms. By integrating their digital diabetes management solutions with medication regimens, electronic health records, and telemedicine services, these companies can offer comprehensive and seamless healthcare experiences for individuals with diabetes. Other than this, understanding the importance of patient engagement and empowerment in diabetes care, key players have focused on developing user-friendly and patient-centric solutions. They prioritize user experience, offering intuitive interfaces, educational resources, and personalized coaching to encourage self-management and lifestyle changes. The goal is to foster long-term engagement and adherence to treatment plans, leading to improved health outcomes for patients. Besides this, recognizing the sensitivity of health data, major players have placed a strong emphasis on data security and privacy. They comply with regulatory standards such as HIPAA (Health Insurance Portability and Accountability Act) and GDPR (General Data Protection Regulation) to ensure the safe storage and transmission of patient information. This commitment to data security builds trust among users and healthcare professionals, further driving the adoption of their digital diabetes management solutions.

The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories

ACON Laboratories Inc

Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation)

Becton, Dickinson and Company

Dexcom Inc.

F. Hoffmann-La Roche AG

Medtronic plc

Novo Nordisk A/S

Tandem Diabetes Care Inc.

Terumo Corporation

Recent Developments:

Novo Nordisk A/S and Aspect Biosystems, two prominent players in the biotechnology and pharmaceutical industries, recently announced a strategic partnership with the shared objective of advancing the development of bioprinted tissue therapeutics tailored to address the challenges of diabetes and obesity. This collaboration represents a significant step forward in the field of regenerative medicine and holds promising potential for patients suffering from these chronic metabolic disorders.

Tandem Diabetes Care Inc. recently announced the results of a significant meta-analysis involving their Control-IQ technology. This comprehensive study demonstrates the positive clinical impact of automatic correction bolusing on glucose control in individuals with Type 1 diabetes, representing a substantial advancement in diabetes care.

Terumo Corporation and Glooko, a prominent digital health platform specializing in diabetes management, have jointly announced a collaboration aimed at developing a new and innovative solution for diabetes data sharing. This partnership brings together Terumo's expertise in medical devices and Glooko's proficiency in digital health technologies, with the ultimate goal of enhancing diabetes care through improved data accessibility and connectivity.

Key Questions Answered in This Report:

  • How has the global digital diabetes management market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global digital diabetes management market?
  • What is the impact of each driver, restraint, and opportunity on the global digital diabetes management market?
  • What are the key regional markets?
  • Which countries represent the most attractive digital diabetes management market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the digital diabetes management market?
  • What is the breakup of the market based on the device type?
  • Which is the most attractive device type in the digital diabetes management market?
  • What is the competitive structure of the global digital diabetes management market?
  • Who are the key players/companies in the global digital diabetes management market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Digital Diabetes Management Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Smart Glucose Meter
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Smart Insulin Pumps
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Smart Insulin Pens
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Apps
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Device Type

  • 7.1 Handheld Devices
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Wearable Devices
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 ACON Laboratories Inc
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation)
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Becton, Dickinson and Company
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Dexcom Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 F. Hoffmann-La Roche AG
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 SWOT Analysis
    • 13.3.7 Medtronic plc
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Novo Nordisk A/S
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Tandem Diabetes Care Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
    • 13.3.10 Terumo Corporation
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Digital Diabetes Management Market: Major Drivers and Challenges
  • Figure 2: Global: Digital Diabetes Management Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Digital Diabetes Management Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Digital Diabetes Management Market: Breakup by Product Type (in %), 2022
  • Figure 5: Global: Digital Diabetes Management Market: Breakup by Device Type (in %), 2022
  • Figure 6: Global: Digital Diabetes Management Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Digital Diabetes Management (Smart Glucose Meter) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 8: Global: Digital Diabetes Management (Smart Glucose Meter) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 9: Global: Digital Diabetes Management (Smart Insulin Pumps) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Digital Diabetes Management (Smart Insulin Pumps) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Digital Diabetes Management (Smart Insulin Pens) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Digital Diabetes Management (Smart Insulin Pens) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Digital Diabetes Management (Apps) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Digital Diabetes Management (Apps) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Digital Diabetes Management (Handheld Devices) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Digital Diabetes Management (Handheld Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Digital Diabetes Management (Wearable Devices) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Digital Diabetes Management (Wearable Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: North America: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: North America: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: United States: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: United States: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Canada: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Canada: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Asia-Pacific: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Asia-Pacific: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: China: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: China: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Japan: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Japan: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: India: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: India: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: South Korea: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: South Korea: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Australia: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Australia: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Indonesia: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Indonesia: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Others: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Others: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Europe: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Europe: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Germany: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Germany: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: France: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: France: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: United Kingdom: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: United Kingdom: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Italy: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Italy: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Spain: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Spain: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Russia: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Russia: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Others: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Others: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Latin America: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Latin America: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Brazil: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Brazil: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Mexico: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Mexico: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Others: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Others: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Middle East and Africa: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Middle East and Africa: Digital Diabetes Management Market: Breakup by Country (in %), 2022
  • Figure 67: Middle East and Africa: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Global: Digital Diabetes Management Industry: SWOT Analysis
  • Figure 69: Global: Digital Diabetes Management Industry: Value Chain Analysis
  • Figure 70: Global: Digital Diabetes Management Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Digital Diabetes Management Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Digital Diabetes Management Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
  • Table 3: Global: Digital Diabetes Management Market Forecast: Breakup by Device Type (in Million US$), 2023-2028
  • Table 4: Global: Digital Diabetes Management Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 5: Global: Digital Diabetes Management Market: Competitive Structure
  • Table 6: Global: Digital Diabetes Management Market: Key Players